Psyence Biomedical Ltd.
PBM
$1.75
$0.1710.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -2.26% | 0.00% | -165.82% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 8.33% | 0.00% | 33.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -182.08% | 0.00% | 106.44% | 0.00% |
| Change in Net Operating Assets | 0.00% | 136.21% | 0.00% | -407.63% | 0.00% |
| Cash from Operations | 0.00% | 8.53% | 0.00% | -46.35% | 0.00% |
| Capital Expenditure | 0.00% | 94.12% | 0.00% | 46.88% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -62,575.00% | 0.00% | -- | -- |
| Cash from Investing | 0.00% | -40,832.65% | 0.00% | -53.13% | 0.00% |
| Total Debt Issued | -- | -- | -- | -100.00% | 0.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 10.06% | 0.00% | 272.35% | 0.00% |
| Cash from Financing | 0.00% | 9.71% | 0.00% | 136.29% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -75.85% | 0.00% | 250.39% | 0.00% |